HINOVA PHARMACEUTICALS INC.

Other languages Hinova Pharmaceuticals Inc.

Equities

688302

CNE1000059F5

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 13/06/2024 BST			5-day change	1st Jan Change
28.32 ^CNY	-1.12%		+6.87%	-45.61%

04-26	Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-08	China Stocks Fall Ahead of March Economic Data Release	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26
China Stocks Fall Ahead of March Economic Data Release	04-08
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Hinova Receives FDA Proceed Authorization for its IND Application for HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment	06/02/23
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit	28/10/22
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW